Pepose Jay 4
4 · Ocuphire Pharma, Inc. · Filed Apr 13, 2022
Insider Transaction Report
Form 4
Pepose Jay
Director
Transactions
- Award
Stock Option (right to buy)
2022-04-08+50,000→ 50,000 totalExercise: $2.90Exp: 2032-04-07→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]The option will vest with respect to 12,500 shares on March 31, 2023, and then with respect to 1,041 shares on the last day of each month from April 2023 through February 2026 and with respect to 1,065 shares at the end of March 2026, subject to the Reporting Person's continuing service through each applicable vesting date.